Potential roles of adropin in central nervous system: Review of current literature

Frontiers in Molecular Biosciences

Volumn 3, Issue JUN, 2016, Pages

  Shahjouei, Shima ^a   Ansari, Saeed ^b   Pourmotabbed, Tayebeh ^b   Zand, Ramin ^b,c  

^a TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b UNIVERSITY OF TENNESSEE HEALTH SCIENCE CENTER   (United States)

^c VIRGINIA BIOINFORMATICS INSTITUTE   (United States)

Author keywords

Adropin; Biomarker; Cellular signaling pathways; Neurodegenerative disease; Neuroprotection; Predictor; Therapeutic

Indexed keywords

EID: 85037047337     PISSN: None     EISSN: 2296889X     Source Type: Journal    
DOI: 10.3389/fmolb.2016.00025     Document Type: Review

References (100)

1. Altincik, A., and Sayin, O. (2015). Evaluation of the relationship between serum adropin levels and blood pressure in obese children. J. Pediatr. Endocrinol. Metab. 28, 1095-1100. doi: 10.1515/jpem-2015-0051
2. Altintas, O., Kumas, M., and Altintas, M. (2016). Neuroprotective effect of ischemic preconditioning via modulating the expression of adropin and oxidative markers against transient cerebral ischemia in diabetic rats. Peptides 79, 31-38. doi: 10.1016/j.peptides.2016.03.011
3. Annovazzi, L., Mellai, M., Caldera, V., Valente, G., Tessitore, L., and Schiffer, D. (2009). mTOR, S6 and AKT expression in relation to proliferation and apoptosis/autophagy in glioma. Anticancer Res. 29, 3087-3094
4. Aydin, S. (2014). Three new players in energy regulation: preptin, adropin and irisin. Peptides 56, 94-110. doi: 10.1016/j.peptides.2014.03.021
5. Aydin, S., Kuloglu, T., Aydin, S., Eren, M. N., Yilmaz, M., Kalayci, M., et al. (2013). Expression of adropin in rat brain, cerebellum, kidneys, heart, liver, and pancreas in streptozotocin-induced diabetes. Mol. Cell. Biochem. 380, 73-81. doi: 10.1007/s11010-013-1660-4
6. Aydin, S., Kuloglu, T., Aydin, S., Kalayci, M., and Yilmaz, M., çakmak, T., et al. (2014). Elevated adropin: a candidate diagnostic marker for myocardial infarction in conjunction with troponin-I. Peptides 58, 91-97. doi: 10.1016/j.peptides.2014.06.001
7. Beaulieu, J.-M., Gainetdinov, R. R., and Caron, M. G. (2007). The Akt-GSK-3 signaling cascade in the actions of dopamine. Trends Pharmacol. Sci. 28, 166-172. doi: 10.1016/j.tips.2007.02.006
8. Blanco-aparicio, C., Renner, O., Leal, J. F. M., and Carnero, A. (2007). PTEN, more than the AKT Pathway. Carcinogenesis 28, 1379-1386. doi: 10.1093/carcin/bgm052
9. Burke, R. E. (2007). Inhibition of mapk and stimulation of akt kinase signaling pathways: two approaches with therapeutic potential in the treatment of neurodegenerative disease. Pharmacol. Ther. 114, 261-277. doi: 10.1016/j.pharmthera.2007.02.002
10. Canals, J. M. (2004). Brain-derived neurotrophic factor regulates the onset and severity of motor dysfunction associated with enkephalinergic neuronal degeneration in huntington's disease. J. Neurosci. 24, 7727-7739. doi: 10.1523/JNEUROSCI.1197-04.2004
11. Cardell, M., Koide, T., and Wieloch, T. (1989). Pyruvate dehydrogenase activity in the rat cerebral cortex following cerebral ischemia. J. Cereb. Blood Flow Metab. 9, 350-357. doi: 10.1038/jcbfm.1989.53
12. Celik, A., Balin, M., Kobat, M. A., Erdem, K., Baydas, A., Bulut, M., et al. (2013). Deficiency of a new protein associated with cardiac syndrome X; called adropin. Cardiovasc. Ther. 31, 174-178. doi: 10.1111/1755-5922.12025
13. Chen, H., Qu, Y., Tang, B., Xiong, T., and Mu, D. (2012). Role of mammalian target of rapamycin in hypoxic or ischemic brain injury: potential neuroprotection and limitations. Rev. Neurosci. 23, 279-287. doi: 10.1515/revneuro-2012-0001
14. Cho, S. (2005). The class B scavenger receptor CD36 mediates free radical production and tissue injury in cerebral ischemia. J. Neurosci. 25, 2504-2512. doi: 10.1523/JNEUROSCI.0035-05.2005
15. Cho, S. (2012). CD36 as a therapeutic target for endothelial dysfunction in stroke. Curr. Pharm. Des. 18, 3721-3730. doi: 10.2174/138161212802002760
16. Chong, Z. Z., Li, F., and Maiese, and, K. (2005). Activating Akt and the brain's resources to drive cellular survival and prevent inflammatory injury. Histol. Histopathol. 20, 299-315
17. Colin, E., Régulier, E., Perrin, V., Dürr, A., Brice, A., Aebischer, P., et al. (2005). Akt is altered in an animal model of Huntington's disease and in patients. Eur. J. Neurosci. 21, 1478-1488. doi: 10.1111/j.1460-9568.2005.03985.x
18. Demircelik, B. (2014). Adropin: a new marker for predicting late saphenous vein graft disease after coronary artery bypass. Grafting 37, 338-344
19. Demircelik, B., and Kurtul, A. (2015). The relationship between adropin levels and the slow coronary flow phenomenon. Ind. J. Clin. Biochem. 30, 412-417. doi: 10.1007/s12291-014-0470-0
20. Emamian, E. S., Hall, D., Birnbaum, M. J., Karayiorgou, M., and Gogos, J., a (2004). Convergent evidence for impaired AKT1-GSK3beta signaling in schizophrenia. Nat. Genet. 36, 131-137. doi: 10.1038/ng1296
21. Franke, T. F., Hornik, C. P., Segev, L., Shostak, G. A., and Sugimoto, C. (2003). PI3K/Akt and apoptosis: size matters. Oncogene 22, 8983-8998. doi: 10.1038/sj.onc.1207115
22. Ganesh Kumar, K., Zhang, J., Gao, S., Rossi, J., McGuinness, O. P., Halem, H. H., et al. (2012). Adropin deficiency is associated with increased adiposity and insulin resistance. Obesity 20, 1394-1402. doi: 10.1038/oby.2012.31
23. Gao, S., Mcmillan, R. P., Zhu, Q., Lopaschuk, G. D., Hulver, M. W., and Butler, A. A. (2015). Therapeutic effects of adropin on glucose tolerance and substrate utilization in diet-induced obese mice with insulin resistance. Mol. Metab. 4, 1-15. doi: 10.1016/j.molmet.2015.01.005
24. Gao, X., Zhang, H., Takahashi, T., Hsieh, J., Liao, J., Steinberg, G., et al. (2008). The Akt signaling pathway contributes to postconditioning's protection against stroke; the protection is associated with the MAPK and PKC pathways. J. Neurochem. 105, 943-955. doi: 10.1111/j.1471-4159.2008.05218.x
25. Giralt, A., Torres-peraza, J. F., Canals, J. M., and D.I. M. (2010). PH domain leucine-rich repeat protein phosphatase 1 contributes to maintain the activation of the PI3K/Akt pro-survival pathway in Huntington's disease striatum. Cell Death Differ. 17, 324-335. doi: 10.1038/cdd.2009.127
26. Gozal, D., Kheirandish-Gozal, L., Bhattacharjee, R., Molero-Ramirez, H., Tan, H.-L., and Bandla, H. P. R. (2013). Circulating adropin concentrations in pediatric obstructive sleep apnea: potential relevance to endothelial function. J. Pediatr. 163, 1122-1126. doi: 10.1016/j.jpeds.2013.05.040
27. Griffin, R. J., Moloney, A., Kelliher, M., Johnston, J. A., Ravid, R., Dockery, P., et al. (2005). Activation of Akt/PKB, increased phosphorylation of Akt substrates and loss and altered distribution of Akt and PTEN are features of Alzheimer's disease pathology. J. Neurochem. 93, 105-117. doi: 10.1111/j.1471-4159.2004.02949.x
28. Gu, X., Li, H., Zhu, X., Gu, H., and Chen, J. (2015). Inverse correlation between plasma adropin and ET-1 levels in essential hypertension a cross-sectional study. Medicine (Baltimore). 94, 1-5. doi: 10.1097/MD.0000000000001712
29. Hanumanthappa, P., Densi, A., and Krishnamurthy, R. G. (2014). Glycogen Synthase Kinase-β3 in Ischemic Neuronal Death. Curr. Neurovasc. Res. 11, 271-278. doi: 10.2174/1567202611666140520151002
30. Hassan, A. (2004). Endothelial nitric oxide gene haplotypes and risk of cerebral small-vessel disease. Stroke 35, 654-659. doi: 10.1161/01.STR.0000117238.75736.53
31. Hernandez-Guillamon, M., Martinez-Saez, E., Delgado, P., Domingues-Montanari, S., Boada, C., Penalba, A., et al. (2012). MMP-2/MMP-9 plasma level and brain expression in cerebral amyloid angiopathy-associated hemorrhagic stroke. Brain Pathol. 22, 133-141. doi: 10.1111/j.1750-3639.2011.00512.x
32. Hoffmeister-Ullerich, S. A. H., Süsens, U., and Schaller, H. C. (2004). The orphan G-protein-coupled receptor GPR19 is expressed predominantly in neuronal cells during mouse embryogenesis. Cell Tissue Res. 318, 459-463. doi: 10.1007/s00441-004-0948-9
33. Hossain, M. S., Mineno, K., and Katafuchi, T. (2016). Neuronal orphan g-protein coupled receptor proteins mediate plasmalogens-induced activation of ERK and Akt signaling. PLoS ONE 11:e0150846. doi: 10.1371/journal.pone.0150846
34. Humbert, S., Bryson, E., A., Cordelières, F. P., Connors, N. C., Datta, S. R., Finkbeiner, S., et al. (2002). The IGF-1/Akt pathway is neuroprotective in Huntington's disease and involves huntingtin phosphorylation by Akt. Dev. Cell 2, 831-837. doi: 10.1016/S1534-5807(02)00188-0
35. Ikeda, M., Iwata, N., Suzuki, T., Kitajima, T., Yamanouchi, Y., Kinoshita, Y., et al. (2004). Association of AKT1 with schizophrenia confirmed in a Japanese population. Biol. Psychiatry 56, 698-700. doi: 10.1016/j.biopsych.2004.07.023
36. Jeynes, B., and Provias, J. (2009). Significant negative correlations between capillary expressed eNOS and Alzheimer lesion burden. Neurosci. Lett. 463, 244-248. doi: 10.1016/j.neulet.2009.07.091
37. Jin, K., Mao, X. O., Batteur, S. P., McEachron, E., Leahy, A., and Greenberg, D. A. (2001). Caspase-3 and the regulation of hypoxic neuronal death by vascular endothelial growth factor. Neuroscience 108, 351-358. doi: 10.1016/S0306-4522(01)00154-3
38. Jin, K., Zhu, Y., Sun, Y., Mao, X. O., Xie, L., and Greenberg, D. A. (2002). Vascular endothelial growth factor (VEGF) stimulates neurogenesis in vitro and in vivo. Proc. Natl. Acad. Sci. U.S.A. 99, 11946-11950. doi: 10.1073/pnas.182296499
39. Jope, R. S. (2011). Glycogen synthase kinase-3 in the etiology and treatment of mood disorders. Front. Mol. Neurosci. 4:16. doi: 10.3389/fnmol.2011.00016
40. Kalkman, H. O. (2006). The role of the phosphatidylinositide 3-kinase-protein kinase B pathway in schizophrenia. Pharmacol. Ther. 110, 117-134. doi: 10.1016/j.pharmthera.2005.10.014
41. Karege, F., Méary, A., Perroud, N., Jamain, S., Leboyer, M., Ballmann, E., et al. (2012). Genetic overlap between schizophrenia and bipolar disorder: a study with AKT1 gene variants and clinical phenotypes. Schizophr. Res. 135, 8-14. doi: 10.1016/j.schres.2011.12.015
42. Kim, H.-W., Rapoport, S. I., and Rao, J. S. (2010). Altered expression of apoptotic factors and synaptic markers in postmortem brain from bipolar disorder patients. Neurobiol. Dis. 37, 596-603. doi: 10.1016/j.nbd.2009.11.010
43. Kumar, K. G., Trevaskis, J. L., Lam, D. D., Sutton, G. M., Koza, R. A., Chouljenko, V. N., et al. (2008). Identification of adropin as a secreted factor linking dietary macronutrient intake with energy homeostasis and lipid metabolism. Cell Metab. 8, 468-481. doi: 10.1016/j.cmet.2008.10.011
44. Lee, P. H., Bang, O. Y., Hwang, E. M., Lee, J. S., Joo, U. S., Mook-Jung, I., et al. (2005). Circulating beta amyloid protein is elevated in patients with acute ischemic stroke. J. Neural Transm. 112, 1371-1379. doi: 10.1007/s00702-004-0274-0
45. Levy, O., a., Malagelada, C., and Greene, L., A. (2009). Cell death pathways in Parkinson's disease: proximal triggers, distal effectors, and final steps. Apoptosis 14, 478-500. doi: 10.1007/s10495-008-0309-3
46. Li, L., Xie, W., Zheng, X. L., Yin, W. D., and Tang, C. K. (2016). A novel peptide adropin in cardiovascular diseases. Clin. Chim. Acta 453, 107-113. doi: 10.1016/j.cca.2015.12.010
47. Li, N., Lee, B., Liu, R.-J., Banasr, M., Dwyer, J. M., Iwata, M., et al. (2010). mTOR-dependent synapse formation underlies the rapid antidepressant effects of NMDA antagonists. Science 329, 959. doi: 10.1126/science.1190287
48. Li, W., Yang, Y., Hu, Z., Ling, S., and Fang, M. (2015). Neuroprotective effects of DAHP and Triptolide in focal cerebral ischemia via apoptosis inhibition and PI3K/Akt/mTOR pathway activation. Front. Neuroanat. 9:48. doi: 10.3389/fnana.2015.00048
49. Li, X., and Jope, R. S. (2010). Is glycogen synthase kinase-3 a central modulator in mood regulation? Neuropsychopharmacology 35, 2143-2154. doi: 10.1038/npp.2010.105
50. Lian, W., Gu, X., Qin, Y., and Zheng, X. (2011). Elevated plasma levels of adropin in heart failure patients. Intern. Med. 50, 1523-1527. doi: 10.2169/internalmedicine.50.5163
51. Lin, H., Wu, C., and Huang, C. (2010). The Akt-endothelial nitric oxide synthase pathway in hypoxic-ischemic tolerance in the neonatal rat brain. Stroke 1543-1551. doi: 10.1161/STROKEAHA.109.574004
52. Lovren, F., Pan, Y., Quan, A., Singh, K. K., Shukla, P. C., Gupta, M., et al. (2010). Adropin is a novel regulator of endothelial function. Circulation 122, S185-S192. doi: 10.1161/CIRCULATIONAHA.109.931782
53. Machado-Vieira, R., Zanetti, M. V., Teixeira, A. L., Uno, M., Valiengo, L. L., Soeiro-de-Souza, M. G., et al. (2015). Decreased AKT1/mTOR pathway mRNA expression in short-term bipolar disorder. Eur. Neuropsychopharmacol. 25, 468-473. doi: 10.1016/j.euroneuro.2015.02.002
54. Manning, B. D., and Cantley, L. C. (2007). AKT/PKB signaling: navigating downstream. Cell 129, 1261-1274. doi: 10.1016/j.cell.2007.06.009
55. Martin, E., Rosenthal, R. E., and Fiskum, G. (2005). Pyruvate dehydrogenase complex: Metabolic link to ischemic brain injury and target of oxidative stress. J. Neurosci. Res. 79, 240-247. doi: 10.1002/jnr.20293
56. Mattson, M. P., Duan, W., Pedersen, W. A., and Culmsee, C. (2001). Neurodegenerative disorders and ischemic brain diseases. Apoptosis 6, 69-81. doi: 10.1023/A:1009676112184
57. Mizukami, Y., Fujiki, K., Duerr, E.-M., Gala, M., Jo, W.-S., Zhang, X., et al. (2006). Hypoxic regulation of vascular endothelial growth factor through the induction of phosphatidylinositol 3-kinase/Rho/ROCK and c-Myc. J. Biol. Chem. 281, 13957-13963. doi: 10.1074/jbc. M511763200
58. Mu, D., Jiang, X., Sheldon, R. A., Fox, C. K., Hamrick, S. E. G., Vexler, Z. S., et al. (2003). Regulation of hypoxia-inducible factor 1a and induction of vascular endothelial growth factor in a rat neonatal stroke model. Neurobiol. Dis. 14, 524-534. doi: 10.1016/j.nbd.2003.08.020
59. Noshita, N., Lewén, A., Sugawara, T., and Chan, P. H. (2001). Evidence of phosphorylation of Akt and neuronal survival after transient focal cerebral ischemia in mice. J. Cereb. Blood Flow Metab. 21, 1442-1450. doi: 10.1097/00004647-200112000-00009
60. Nuzzo, D., Picone, P., Baldassano, S., Caruana, L., Messina, E., Gammazza, A. M., et al. (2015). Insulin resistance as common molecular denominator linking obesity to Alzheimer's disease. Curr. Alzheimer Res. 12, 723-35. doi: 10.2174/1567205012666150710115506
61. O'Dowd, B. F., Nguyen, T., Lynch, K. R., Kolakowski, L. F., Thompson, M., Cheng, R., et al. (1996). A novel gene codes for a putative G protein-coupled receptor with an abundant expression in brain. FEBS Lett. 394, 325-329. doi: 10.1016/0014-5793(96)00901-5
62. Ogurel, T., Ogurel, R., and Topuz, M., örnek, N., and örnek, K. (2016). Plasma adropin level in patients with pseudoexfoliation. Int. Ophthalmol. doi: 10.1007/s10792-016-0185-8. [Epub ahead of print]
63. Pacary, E., Legros, H., Valable, S., Duchatelle, P., Lecocq, M., Petit, E., et al. (2006). Synergistic effects of CoCl(2) and ROCK inhibition on mesenchymal stem cell differentiation into neuron-like cells. J. Cell Sci. 119, 2667-2678. doi: 10.1242/jcs.03004
64. Pacary, E., Petit, E., and Bernaudin, M. (2008). Concomitant inhibition of prolyl hydroxylases and ROCK initiates differentiation of mesenchymal stem cells and PC12 towards the neuronal lineage. Biochem. Biophys. Res. Commun. 377, 400-406. doi: 10.1016/j.bbrc.2008.09.145
65. Pacary, E., Tixier, E., Coulet, F., Roussel, S., Petit, E., and Bernaudin, M. (2007). Crosstalk between HIF-1 and ROCK pathways in neuronal differentiation of mesenchymal stem cells, neurospheres and in PC12 neurite outgrowth. Mol. Cell. Neurosci. 35, 409-423. doi: 10.1016/j.mcn.2007.04.002
66. Papazoglou, I. K., Jean, A., Gertler, A., Taouis, M., and Vacher, C.-M. (2014). Hippocampal GSK3β as a molecular link between obesity and depression. Mol. Neurobiol. 363-374. doi: 10.1007/s12035-014-8863-x
67. Peng, B., Guo, Q., He, Z., Ye, Z., Yuan, Y., Wang, N., et al. (2012). Remote ischemic postconditioning protects the brain from global cerebral ischemia/reperfusion injury by up-regulating endothelial nitric oxide synthase through the PI3K/Akt pathway. Brain Res. 1445, 92-102. doi: 10.1016/j.brainres.2012.01.033
68. Primo, L., Ferrandi, C., Roca, C., Marchiò, S., di Blasio, L., Alessio, M., et al. (2005). Identification of CD36 molecular features required for its in vitro angiostatic activity. FASEB J. 19, 1713-1715. doi: 10.1096/fj.05-3697fje
69. Ries, V., Henchcliffe, C., Kareva, T., Rzhetskaya, M., Bland, R., During, M. J., et al. (2006). Oncoprotein Akt/PKB induces trophic effects in murine models of Parkinson's disease. Proc. Natl. Acad. Sci. U.S.A. 103, 18757-18762. doi: 10.1073/pnas.0606401103
70. Rosenthal, R. E., Williams, R., Bogaert, Y. E., Getson, P. R., and Fiskum, G. (1992). Prevention of postischemic canine neurological injury through potentiation of brain energy metabolism by acetyl-L-carnitine. Stroke 23, 1312-1318. doi: 10.1161/01.STR.23.9.1312
71. Schwab, S. G., Hoefgen, B., Hanses, C., Hassenbach, M. B., Albus, M., Lerer, B., et al. (2005). Further evidence for association of variants in the AKT1 gene with schizophrenia in a sample of European sib-pair families. Biol. Psychiatry 58, 446-450. doi: 10.1016/j.biopsych.2005.05.005
72. Shentu, T. P., Titushkin, I., Singh, D. K., Gooch, K. J., Subbaiah, P. V., Cho, M., et al. (2010). oxLDL-induced decrease in lipid order of membrane domains is inversely correlated with endothelial stiffness and network formation. Am. J. Physiol. Cell Physiol. 299, C218-C229. doi: 10.1152/ajpcell.00383.2009
73. Shimotake, J., Derugin, N., Wendland, M., Vexler, Z. S., and Donna, M., Ferriero (2010). Vascular endothelial growth factor receptor-2 inhibition promotes cell death and limits endothelial cell proliferation in a neonatal rodent model of stroke. Stroke 41, 343-349. doi: 10.1161/STROKEAHA.109.564229
74. Sondell, M., Sundler, F., and Kanje, M. (2000). Vascular endothelial growth factor is a neurotrophic factor which stimulates axonal outgrowth through the flk-1 receptor. Eur. J. Neurosci. 12, 4243-4254. doi: 10.1046/j.0953-816X.2000.01326.x
75. Stein, L. M., Yosten, G. L. C., and Samson, W. K. (2016). Adropin acts in brain to inhibit water drinking: potential interaction with the orphan G protein-coupled receptor, GPR19. Am. J. Physiol. Regul. Integr. Comp. Physiol. 310, R476-R480. doi: 10.1152/ajpregu.00511.2015
76. Sun, Y., Jin, K., Xie, L., Childs, J., Mao, X. O., Logvinova, A., et al. (2003). VEGF-induced neuroprotection, neurogenesis, and angiogenesis after focal cerebral ischemia. J. Clin. Invest. 111, 1843-1851. doi: 10.1172/JCI200317977
77. Tan, X.-L., Xue, Y.-Q., Ma, T., Wang, X., Li, J. J., Lan, L., et al. (2015). Partial eNOS deficiency causes spontaneous thrombotic cerebral infarction, amyloid angiopathy and cognitive impairment. Mol. Neurodegener. 10, 24. doi: 10.1186/s13024-015-0020-0
78. Thiselton, D. L., Vladimirov, V. I., Kuo, P.-H., McClay, J., Wormley, B., Fanous, A., et al. (2008). AKT1 Is associated with schizophrenia across multiple symptom dimensions in the irish study of high density schizophrenia families. Biol. Psychiatry 63, 449-457. doi: 10.1016/j.biopsych.2007.06.005
79. Timmons, S., Coakley, M. F., Moloney, A. M., and Neill, C. O. (2009). Akt signal transduction dysfunction in Parkinson' s disease. Neurosci. Lett. 467, 30-35. doi: 10.1016/j.neulet.2009.09.055
80. Tiwari, S. K., Seth, B., Agarwal, S., Yadav, A., Karmakar, M., Gupta, S. K., et al. (2015). Ethosuximide induces hippocampal neurogenesis and reverses cognitive deficits in an Amyloid-β toxin-induced alzheimer rat model via the phosphatidylinositol 3-kinase (PI3K)/Akt/Wnt/β-Catenin Pathway. J Biol Chem 290, 28540-28558. doi: 10.1074/jbc. M115.652586
81. Ueno, M., Chiba, Y., Matsumoto, K., Murakami, R., Fujihara, R., Kawauchi, M., et al. (2016). Blood-brain barrier damage in vascular dementia. Neuropathology 36, 115-124. doi: 10.1111/neup.12262
82. Wang, H., Wang, G., Yu, Y., and Wang, Y. (2009). The role of phosphoinositide-3-kinase/Akt pathway in propofol-induced postconditioning against focal cerebral ischemia-reperfusion injury in rats. Brain Res. 1297, 177-184. doi: 10.1016/j.brainres.2009.08.054
83. Weidemann, A., Breyer, J., Rehm, M., Eckardt, K.-U., Daniel, C., Cicha, I., et al. (2013). HIF-1a activation results in actin cytoskeleton reorganization and modulation of Rac-1 signaling in endothelial cells. Cell Commun. Signal. 11, 80. doi: 10.1186/1478-811X-11-80
84. Willmot, M., Gray, L., Gibson, C., Murphy, S., and Bath, P. M. W. (2005). A systematic review of nitric oxide donors and l-arginine in experimental stroke; effects on infarct size and cerebral blood flow. Nitric Oxide 12, 141-149. doi: 10.1016/j.niox.2005.01.003
85. Winkler, D. T., Bondolfi, L., Herzig, M. C., Jann, L., Calhoun, M. E., Wiederhold, K. H., et al. (2001). Spontaneous hemorrhagic stroke in a mouse model of cerebral amyloid angiopathy. J. Neurosci. 21, 1619-1627
86. Wojciak-Stothard, B., and Ridley, A. J. (2002). Rho GTPases and the regulation of endothelial permeability. Vascul. Pharmacol. 39, 187-199. doi: 10.1016/S1537-1891(03)00008-9
87. Wojciak-Stothard, B., Tsang, L. Y. F., and Hawrth, S. G. (2005). Rac and Rho play opposing roles in the regulation of hypoxia/reoxygenation-induced permeability changes in pulmonary artery endothelial cells. Am. J. Physiol. Lung Cell. Mol. Physiol. 288, L749-L760. doi: 10.1152/ajplung.00361.2004
88. Wojciak-Stothard, B., Tsang, L. Y. F., Paleolog, E., Hall, S. M., and Haworth, S. G. (2006). Rac1 and RhoA as regulators of endothelial phenotype and barrier function in hypoxia-induced neonatal pulmonary hypertension. Am. J. Physiol. Lung Cell. Mol. Physiol. 290, L1173-L1182. doi: 10.1152/ajplung.00309.2005
89. Wong, C.-M., Wang, Y., Lee, J. T. H., Huang, Z., Wu, D., Xu, A., et al. (2014). Adropin is a brain membrane-bound protein regulating physical activity via the NB-3/notch signaling pathway in mice. J. Biol. Chem. 289, 25976-25986. doi: 10.1074/jbc. M114.576058
90. Woodhouse, L., Scutt, P., Krishnan, K., Berge, E., Gommans, J., Ntaios, G., et al. (2015). Effect of hyperacute administration (within 6 hours) of transdermal glyceryl trinitrate, a nitric oxide donor, on outcome after stroke. Stroke 46, 00-00. doi: 10.1161/STROKEAHA.115.009647
91. Wu, H., Yang, S., Dai, J., Qiu, Y., Miao, Y., and Zhang, X. (2015). Combination of early and delayed ischemic postconditioning enhances brain-derived neurotrophic factor production by upregulating the ERK-CREB pathway in rats with focal ischemia. Mol. Med. Rep. 6427-6434. doi: 10.3892/mmr.2015.4327
92. Wu, L., Fang, J., Chen, L., Zhao, Z., Luo, Y., Lin, C., et al. (2014). Low serum adropin is associated with coronary atherosclerosis in type 2 diabetic and non-diabetic patients. Clin. Chem. Lab. Med. 52, 751-758. doi: 10.1515/cclm-2013-0844
93. Yang, C., DeMars, K. M., Hawkins, K. E., and Candelario-Jalil, E. (2016). Adropin reduces paracellular permeability of rat brain endothelial cells exposed to ischemia-like conditions. Peptides 81, 29-37. doi: 10.1016/j.peptides.2016.03.009
94. Yu, H., Zhao, P., Wu, M., Liu, J., and Yin, W. (2014). Serum adropin levels are decreased in patients with acute myocardial infarction. Regul. Pept. 190, 46-49. doi: 10.1016/j.regpep.2014.04.001
95. Yu, X. B., Shacka, J. J., Eells, J. B., Suarez-Quian, C., Przygodzki, R. M., Beleslin-Cokic, B., et al. (2002). Erythropoietin receptor signalling is required for normal brain development. Development 129, 505-516
96. Zhao, L. P., Xu, W. T., Wang, L., You, T., Chan, S. P., Zhao, X., et al. (2015b). Serum adropin level in patients with stable coronary artery disease. Hear. Lung Circ. 24, 975-979. doi: 10.1016/j.hlc.2015.03.008
97. Zhao, L. P., You, T., Chan, S. P., Chen, J. C., and Xu, W. T. (2015a). Adropin is associated with hyperhomocysteine and coronary atherosclerosis. Exp. Ther. Med. 1065-1070
98. Zhao, Y., Li, J., Tang, Q., Zhang, P., Jing, L., Chen, C., et al. (2014). Regulation of extracellular signal? regulated kinase 1/2 influences hippocampal neuronal survival in a rat model of diabetic cerebral ischemia. Neural Regen. Res. 9, 749-756. doi: 10.4103/1673-5374.131581
99. Zhao, Z., Ksiezak-Reding, H., Riggio, S., Haroutunian, V., and Pasinetti, G. M. (2006). Insulin receptor deficits in schizophrenia and in cellular and animal models of insulin receptor dysfunction. Schizophr. Res. 84, 1-14. doi: 10.1016/j.schres.2006.02.009
100. Zhu, Y. M., Wang, C. C., Chen, L., Qian, L. B., Ma, L. L., Yu, J., et al. (2013). Both PI3K/Akt and ERK1/2 pathways participate in the protection by dexmedetomidine against transient focal cerebral ischemia/reperfusion injury in rats. Brain Res. 1494, 1-8. doi: 10.1016/j.brainres.2012.11.047